Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories is a one-of-a-kind IP licensing company with a strong focus on consumer-linked markets. The company's shift towards premium offerings such as Atmos and Vision is improving its per-unit economics and is expected to drive growth in the high single digits as macro headwinds ease. With a strong balance sheet, consistent free cash flow, and expanding adoption of its technologies in various markets, we see plenty of potential for this company and reiterate our Buy rating and $85 price target.

Bears say

Dolby Laboratories is facing challenges with declining margins and operating expenses as well as supply constraints for chips which may impact their foundational revenues. However, the company is showing strong growth potential with the increasing adoption of their Atmos, Vision, and Patents technologies, positioning them for accelerated growth in the future. Despite the current macro environment, the company’s overall execution is solid and its stock is undervalued, making it a potentially good investment for patient investors.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.